Speaker Announcement
February 10, 2026 | Central European Time
We are pleased to welcome Dr. Jürgen Scheuenpflug as a featured speaker at the Virtual Liquid Biopsy Symposium.
Dr. Scheuenpflug is Executive Director and Head of Strategic Innovation at Merck Healthcare, where he leads strategic initiatives at the intersection of life science innovation, translational research, and emerging healthcare technologies.
With extensive experience in the life sciences industry, Dr. Scheuenpflug works on identifying and advancing breakthrough technologies with the potential to transform diagnostics and precision medicine. His work focuses on bridging scientific innovation with clinical and commercial realities, including the development, validation, and adoption of liquid biopsy solutions across research and clinical settings. He actively explores partnerships, technology platforms, and regulatory pathways that accelerate the translation of liquid biopsy from discovery to real-world impact.
In this talk, Dr. Scheuenpflug will provide an industry perspective on the evolving liquid biopsy landscape. He will discuss key challenges in demonstrating clinical utility, integrating liquid biopsy into healthcare systems, and achieving regulatory and reimbursement acceptance. The talk will also highlight emerging opportunities in technology innovation, clinical applications, and cross-sector collaboration that are shaping the future of liquid biopsy.
Join us for an insightful discussion on how industry is driving the next phase of liquid biopsy adoption and impact.
This conference is organized by Impact Research Communications (IRC)
More info: https://liquidbio.ircconferences.net/ | Advances in Liquid Biopsy
